Fri, March 8, 2024
Thu, March 7, 2024
Wed, March 6, 2024

Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $6 on, Mar 7th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-increased-target-to-6-on-mar-7th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Increased Target from $5.5 to $6 on, Mar 7th, 2024.

Oren has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $4 on, Friday, November 10th, 2023

Publication Contributing Sources